Gatt Technologies

About Gatt Technologies

GATT Technologies, accessible at gatt-tech.com, is a pioneering startup in the medical technology sector. The company specializes in developing advanced hemostatic (bleeding control) and sealant products designed to improve surgical outcomes. GATT's innovative platform leverages a synthetic POx polymer, a next-generation material that enhances the effectiveness of their products in controlling bleeding and sealing tissues during surgeries.

GATT's product portfolio includes a range of solutions such as fast-acting hemostatic patches, powders, sprays, and tapes. These products are particularly beneficial in surgeries where normal blood clotting is difficult, such as general, cardiovascular, and lung surgeries, as well as minimally invasive laparoscopic and robotic procedures. Additionally, GATT is expanding its offerings to address other medical needs, including bone regeneration, anti-adhesion (preventing tissues from sticking together), vascular (related to blood vessels), and ophthalmology (eye-related) applications.

The company primarily serves hospitals, surgical centers, and healthcare providers who perform complex surgical procedures. By offering a comprehensive suite of products, GATT aims to be a one-stop shop for surgical hemostatic and sealant solutions. This business model not only addresses a critical need in the medical field but also positions GATT as a key player in the surgical products market.

GATT generates revenue by selling its products directly to healthcare institutions and through partnerships with medical device distributors. The company's innovative approach and broad product range provide it with a competitive edge in the growing market for surgical hemostats and sealants.

In summary, GATT Technologies is revolutionizing surgical care with its advanced hemostatic and sealant products, serving a wide range of surgical needs and improving patient outcomes.